Verona Pharma PLC American Depositary Share (VRNA) Competitors

Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) and BeOne Medicines (NASDAQ:ONC) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

Do institutionals & insiders have more ownership in VRNA or ONC?

85.9% of Verona Pharma PLC American Depositary Share shares are held by institutional investors. Comparatively, 48.6% of BeOne Medicines shares are held by institutional investors. 4.8% of Verona Pharma PLC American Depositary Share shares are held by insiders. Comparatively, 6.6% of BeOne Medicines shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Is VRNA or ONC more profitable?

BeOne Medicines has a net margin of -3.89% compared to Verona Pharma PLC American Depositary Share's net margin of -36.62%. BeOne Medicines' return on equity of -1.22% beat Verona Pharma PLC American Depositary Share's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verona Pharma PLC American Depositary Share	-36.62%	-21.12%	-9.07%
BeOne Medicines	-3.89%	-1.22%	-0.72%

Which has preferable earnings and valuation, VRNA or ONC?

Verona Pharma PLC American Depositary Share has higher earnings, but lower revenue than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Verona Pharma PLC American Depositary Share, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verona Pharma PLC American Depositary Share	$221.67M	39.23	-$173.42M	-$0.99	-107.33
BeOne Medicines	$3.81B	9.86	-$644.79M	-$1.73	-198.20

Which has more risk & volatility, VRNA or ONC?

Verona Pharma PLC American Depositary Share has a beta of 0.14, meaning that its stock price is 86% less volatile than the S&P 500. Comparatively, BeOne Medicines has a beta of 0.21, meaning that its stock price is 79% less volatile than the S&P 500.

Does the media favor VRNA or ONC?

In the previous week, BeOne Medicines had 2 more articles in the media than Verona Pharma PLC American Depositary Share. MarketBeat recorded 11 mentions for BeOne Medicines and 9 mentions for Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share's average media sentiment score of 1.29 beat BeOne Medicines' score of 0.68 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Verona Pharma PLC American Depositary Share	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BeOne Medicines	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend VRNA or ONC?

Verona Pharma PLC American Depositary Share presently has a consensus price target of $109.00, suggesting a potential upside of 2.58%. BeOne Medicines has a consensus price target of $336.30, suggesting a potential downside of 1.92%. Given Verona Pharma PLC American Depositary Share's higher possible upside, analysts clearly believe Verona Pharma PLC American Depositary Share is more favorable than BeOne Medicines.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Verona Pharma PLC American Depositary Share	0 Sell rating(s)	12 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
BeOne Medicines	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

BeOne Medicines beats Verona Pharma PLC American Depositary Share on 9 of the 16 factors compared between the two stocks.